GWLL Stock Overview
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Goldenwell Biotech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.059 |
| 52 Week High | US$0.25 |
| 52 Week Low | US$0.059 |
| Beta | -0.59 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -80.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| GWLL | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -1.1% | 2.2% |
| 1Y | n/a | -28.3% | 22.8% |
Return vs Industry: Insufficient data to determine how GWLL performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how GWLL performed against the US Market.
Price Volatility
| GWLL volatility | |
|---|---|
| GWLL Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GWLL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GWLL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | Shuang Liu | www.goldenwellbiotech.com |
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing five products, including JI MAI—bovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG – 3D active collagen peptide, as well as Se Plus tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.
Goldenwell Biotech, Inc. Fundamentals Summary
| GWLL fundamental statistics | |
|---|---|
| Market cap | US$5.80m |
| Earnings (TTM) | -US$1.02m |
| Revenue (TTM) | US$2.08k |
2,789x
P/S Ratio-5.7x
P/E RatioIs GWLL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GWLL income statement (TTM) | |
|---|---|
| Revenue | US$2.08k |
| Cost of Revenue | US$1.05k |
| Gross Profit | US$1.04k |
| Other Expenses | US$1.02m |
| Earnings | -US$1.02m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.01 |
| Gross Margin | 49.76% |
| Net Profit Margin | -48,866.78% |
| Debt/Equity Ratio | 0% |
How did GWLL perform over the long term?
See historical performance and comparison